Late premature birth increases risk of recurrent hospitalization for respiratory illness
New Rochelle, NY, June 21, 2017–A new study of children up to 2 years of age showed that those born late preterm (34-36 weeks) had a significantly greater risk of recurrent hospitalization due to respiratory illness compared to those who were born full term (>37 weeks). The repeat hospital visits also occurred at an earlier age in the late preterm birth group of children, according to an article in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Pediatric Allergy, Immunology, and Pulmonology website.
Oded Breuer, MD and coauthors from Hadassah-Hebrew University Medical Center, Jerusalem, Israel reported their results in the article entitled "Respiratory Hospitalizations and Rehospitalizations in Infants Born Late Preterm." The children required hospital treatment mainly for wheezing-related illness.
"Late preterm infants comprise the largest segment of premature infants and their numbers are growing. There have been few studies looking at the long-term outcomes of these children and the respiratory risks they face. The study by Breuer et al. is an important contribution highlighting the respiratory risks and morbidity in late preterm births beyond the first few months of life," says Pediatric Allergy, Immunology, and Pulmonology Editor-in-Chief Mary Cataletto, MD, Professor of Clinical Pediatrics, Stony Brook University School of Medicine.
About the Journal
Pediatric Allergy, Immunology, and Pulmonology is a quarterly, peer-reviewed journal published online with open access options and in print that synthesizes the pulmonary, allergy, and immunology communities in the advancement of the respiratory health of children. Led by Editor-in-Chief Mary Cataletto, MD, Professor of Clinical Pediatrics, State University of New York at Stony Brook, the Journal provides comprehensive coverage to further the understanding and optimize the treatment of some of the most common and costly chronic illnesses in children. It includes original translational, clinical, and epidemiologic research; public health, quality improvement, and case control studies; patient education research; and the latest research and standards of care for functional and genetic immune deficiencies and interstitial lung diseases. Tables of content and a sample issue may be viewed on the Pediatric Allergy, Immunology, and Pulmonology website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Journal of Aerosol Medicine and Pulmonary Drug Delivery, Breastfeeding Medicine, and Population Health Management. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publisher's website.